Showing results (1221-1230 of 1,493) with videos related to

Sort By:
Pageof 150
Journal of the American Academy of Dermatology|June 20, 2015
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)Kim Papp, Kristian Reich, Craig L Leonardi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 19, 2024
Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort studyMark Griffiths, Dunia Hatabah, Patrick Sullivan, et al.
Pediatric Pulmonology|September 24, 2016
Genetic medicines for CF: Hype versus realityEric W F W Alton, A Christopher Boyd, Jane C Davies, et al.
Cancer Research|June 11, 2011
PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantationWieger J Norde, Frans Maas, Willemijn Hobo, et al.
Arthritis and Rheumatism|January 1, 2009
The chromosome 7q region association with rheumatoid arthritis in females in a British population is not replicated in a North American case-control seriesBenjamin D Korman, Michael F Seldin, Kimberly E Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphomaD Y Song, R J Jones, J S Welsh, et al.
Plos One|October 13, 2011
The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinctKyra Y L Chua, Torsten Seemann, Paul F Harrison, et al.
American Journal of Human Genetics|March 2, 2002
A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parentsAnnick Raas-Rothschild, Ronald J A Wanders, Petra A W Mooijer, et al.
International Journal of Antimicrobial Agents|March 25, 2022
Genomic characterisation of CC398 MRSA causing severe disease in AustraliaGeoffrey W Coombs, Denise Daley, Princy Shoby, et al.
Plos One|November 19, 2016
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque ToxicologyMark J Selby, John J Engelhardt, Robert J Johnston, et al.
Pageof 150